Actively Recruiting
Patients on Antithrombotics for Colonoscopy
Led by Chinese University of Hong Kong · Updated on 2022-01-18
6000
Participants Needed
1
Research Sites
572 weeks
Total Duration
On this page
Sponsors
C
Chinese University of Hong Kong
Lead Sponsor
B
Beijing Friendship Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The use of antithrombotics (antiplatelet agents and anticoagulants) is increasing with an aging global population.Management of antithrombotics in patients undergoing invasive procedures including gastrointestinal endoscopy remains a challenge. Management approach includes taking a precarious balance between the risk of thromboembolism after interruption of antithrombotics and risk of bleeding with the continuation of antithrombotics. Colonoscopy remains one of the commonest endoscopic procedures performed. The optimal management strategy of different antithrombotics during colonoscopy remains unclear.
CONDITIONS
Official Title
Patients on Antithrombotics for Colonoscopy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be over 18 years of age
- Patients undergoing elective colonoscopy for any indication, who are receiving antithrombotics
- Informed consent is obtained
You will not qualify if you...
- Patients under 18 years of age
- Inability to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
M
Moe Htet Kyaw, MBBS
CONTACT
K
Ka Man Kee, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here